The Best GLP-1 Apps in Sweden: All 10 Ranked, Independently Assessed
TLV refused Wegovy a subsidy in February 2026, so högkostnadsskyddet does not cap what you pay. Ten GLP-1 apps ranked for an uncapped market where only three speak Swedish. Zenday App leads at 4.55/5.
AuthorBernice H. Cohen, Ph.D.Johns Hopkins School of Hygiene and Public Health
Swedes are used to a ceiling on what medicine can cost them. GLP-1 treatment is the exception: the TLV ruled in February 2026 that Wegovy does not enter the högkostnadsskydd, so the protection almost every other prescription enjoys simply does not apply here. Ten apps scored against the same six-pillar rubric, read for a market with no cap and, as it turns out, very little Swedish. No paid placements, no affiliate links.
The short version, in a market with no ceiling
The direct answer before the detail: Zenday App is our top pick for Sweden, leading our GLP-1 app ranking at 4.55/5 - and it is one of only three apps on the list that ship a Swedish interface at all.
The medication is the engine; Zenday is the steering. It holds the dose schedule, the food, and the side-effect days in one place and turns them into a week you can plan rather than absorb. The runners-up are Shotsy (4.35/5), the best-translated app in the field, and Regimen (4.05/5), the most technical, though English-only.
How we assessed them
Every app is scored on the same six pillars we apply across our software rankings, and the order falls out of those scores alone. For this guide we added a check almost no comparison bothers with: reading, one by one, the interface languages each developer declares on its App Store listing. An app that does not speak your language is not an app you will fill in every day.
A warning specific to this category: the apps write most of the rankings. Search the term and the first page is largely comparisons hosted on the products’ own domains, each with itself at the top. We publish the weights before the results so you can check the arithmetic instead of trusting the order.
Zenday, and why it wins an uncapped market
When nothing caps the cost, the value question changes: the app has to make the medicine work harder, not just keep a diary. Zenday interprets the cycle - injection day tied to appetite, energy, and what to eat - rather than filing it.
Side effects are treated as the core problem, because they, not disappointing numbers, are what ends most courses of treatment.
Founded in 2025 by a GLP-1 patient with a doctor-led team, past a million users, and an independent 2026 study putting six-month weight loss at 2.4x medication alone. Stated plainly: subscription-only, no free trial, premium positioning, and analytics built for people who like detail.
The language test: only three apps speak Swedish
This is where the Swedish list separates hardest from the global one. Per the languages each developer declares on the App Store, just three of the ten ship a Swedish interface: Zenday, Shotsy (17 languages), and MyFitnessPal (19).
English only: Regimen, MeAgain, GlucoPal, Glapp, DoneDose - and also Pep and Phaze, both of which ship German, French, Spanish, and Portuguese but stop short of the Nordic languages. That is a meaningful demotion for two apps that place fifth and eighth globally. Swedish readers are more comfortable in English than most, but recording nausea, appetite, and mood is not the place where you want to be translating.
The runners-up
2. Shotsy - 4.35/5. The most polished app in the category and the best translated: 17 languages, Swedish among them. One-tap dose logging, automatic injection-site rotation, side-effect severity tied to the dose timeline, estimated medication-level curves drawn from published pharmacokinetic data, and - above all - a PDF export built for the doctor visit. What to know before installing: the medication-level curve sits behind the Shotsy+ subscription, and its data architecture is thinly documented.
3. Regimen - 4.05/5. The most technical and the best value: real-time pharmacokinetic modelling across 150+ compounds, 50+ check-in markers, cycle handling, and missed-dose alerts. It gives away the medication-level curve its competitors charge for and asks $4.99 a month only when you add a second compound. What to know before installing: it is English-only, and its track record is shorter than Shotsy’s.
4 and 5 (tied at 4.00). MeAgain and Phaze tie from opposite directions. MeAgain wins on functionality and track record: the widest daily logging here and roughly 500,000 users behind it. Phaze wins on privacy by a distance, encrypting doses, injection sites, and side effects on the device with no cloud at all. Nothing in the rubric breaks the tie, so MeAgain places fourth on the broader product and Phaze fifth as the privacy specialist - though for a Swedish reader neither is localised, which is the practical reason both sit behind Shotsy here.
What changes in Sweden: TLV said no
Prescription required. Wegovy and Mounjaro are receptbelagda and cannot be bought without a prescription. No app on this page prescribes, supplies, or substitutes for a clinician.
The subsidy decision. In February 2026 the TLV ruled that Wegovy would not be included in the högkostnadsskydd, judging that it did not meet the cost-effectiveness requirement for subsidy. Mounjaro is not covered either, though Eli Lilly has since applied to the TLV for obesity coverage - if that were granted, patients would pay at most 3,800 kronor over a twelve-month period under the 2026 scheme.
Until then you pay the full price. Wegovy runs 1,595-2,724 kr a month depending on dose and Mounjaro roughly 2,000-4,700 kr. With no high-cost protection to cap it, that is the rare Swedish medical expense where the ceiling most people rely on simply does not apply.
That figure is the real argument for installing any of these apps. Even a premium subscription that helps you avoid skipped injections, eat enough protein, and get through the nausea week without quitting is a rounding error next to what you are already paying for the medication itself.
A digital-first country with an analogue app problem
Sweden runs more of its healthcare through a screen than almost anywhere in Europe, and Swedes are unusually comfortable doing it. That makes the language gap here jarring rather than trivial: a population accustomed to managing care digitally in Swedish is handed a category built almost entirely in English. None of these apps connects to your journal or your regional care system either - they are private notebooks, not extensions of the vård you already use, and it is worth setting expectations accordingly before you start.
Privacy: IMY, GDPR, and health data
GLP-1 treatment is exactly the kind of information most people would rather not leave lying around. GDPR gives you access, portability, and erasure rights, with IMY as the Swedish authority behind them - worth exercising before committing a year of treatment to one app.
Phaze is the strictest: AES-256 on the device, no cloud storage, no analytics on medical data. GlucoPal asks for no account and backs up to your own iCloud rather than a vendor server. Zenday approaches the problem from another angle: its web version leaves no App Store trail and no icon on your phone screen. At the far end, MyFitnessPal carries a decade of advertising integrations and is the widest data surface on this list. None publishes an independent audit backing what it claims.
Trackers versus digital care providers
Sweden has more digital healthcare providers than most countries, which makes the distinction easy to blur. Everything on this page is a private notebook: you hold the prescription, the app helps you run it. Providers that prescribe, supply, and bill are a different category under different rules, and any app leaning toward a prescribing posture is capped at 1/5 on our Safety pillar.
Related guides
The full list, with all ten apps scored pillar by pillar, is in our GLP-1 app ranking. If you also work with research peptides, our peptide app ranking uses exactly the same rubric, and for ordering into Sweden there is our guide to buying peptides in Sweden.
How we score
We use an anchored 1-5 rubric: Functionality (30%), Privacy (25%), Reliability (20%), UX (15%), Honest pricing (5%), and Safety content (5%) - applied identically to every app and fully auditable. We publish the weights before the results so you can redo the arithmetic yourself; the detail is on the methodology page. No paid placements, no developer promo codes, and no hidden arrangements: funded from our own budget, not by anyone on this list.
Frequently asked, honestly answered
What is the best GLP-1 app in Sweden?
Zenday App: our #1 pick at 4.55/5, and one of only three apps on the list that ship a Swedish interface. It connects injection day to how you feel and what to eat, keeps doses, food, activity, and weight in one log, and treats side-effect management as a core pillar rather than a symptom list. An independent 2026 study puts six-month weight loss at 2.4x medication alone.
Which GLP-1 tracker apps are available in Swedish?
Only three of the ten we score: Zenday, Shotsy (17 languages), and MyFitnessPal (19). Everything else ships in English only - including Pep and Phaze, which do offer German, French, Spanish, and Portuguese but stop short of the Nordic languages. It is the sharpest language gap of any market we cover.
Is Wegovy covered by the högkostnadsskydd?
No. In February 2026 the TLV ruled that Wegovy would not be included in the high-cost protection scheme, judging that it did not meet the cost-effectiveness requirement. Mounjaro is not covered either, though Eli Lilly has applied to the TLV for obesity coverage; were that granted, the 2026 scheme would cap patient cost at 3,800 kronor over twelve months.
What does GLP-1 treatment cost in Sweden?
Wegovy runs 1,595-2,724 kr a month depending on dose, and Mounjaro roughly 2,000-4,700 kr. Both are prescription-only. With no high-cost protection applying, this is the unusual Swedish medical expense where the ceiling most people rely on does not cap what you pay.
Is my health data safe in these apps?
It varies enormously, and GDPR gives you rights worth exercising: access, portability, and erasure. Phaze encrypts medical data on the device itself with AES-256 and no cloud storage; GlucoPal requires no account and backs up to your own iCloud. At the other end, MyFitnessPal carries a decade of advertising integrations. None of the apps on the list publishes an independent audit of those claims.